Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00212043
Status:
COMPLETED
Last Update Posted:
2009-10-08
First Post:
2005-09-13
Brief Title:
Phase III Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma
Sponsor:
National University Hospital Singapore
Organization:
National University Hospital Singapore
Organization Data
Organization:
National University Hospital Singapore
Class:
OTHER
Study ID:
CTRG L0899
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National University Hospital Singapore
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |